Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ACAD | ACLX | MOR | ||
| Company | Acadia Pharmaceutica | Arcellx Inc | Morphosys Ag ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 16.90 | 52.08 | 17.55 | ||
| High | 17.57 | 52.45 | 17.61 | ||
| Low | 16.85 | 50.59 | 17.04 | ||
| Last | 17.10 | 51.11 | 17.36 | ||
| Change | +0.39 | -0.81 | -0.68 | ||
| % Change | +2.33% | -1.56% | -3.77% | ||
| Volume | 1,887,700 | 388,000 | 4,541,600 | ||
| 20-Day Average Volume | 1,437,200 | 469,175 | 567,320 | ||
| Previous Close | 16.71 | 51.92 | 18.04 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 17.32 | 56.80 | 18.02 | ||
| 20-Day Raw Stochastic | 38.06% | 8.78% | 27.59% | ||
| 20-Day Relative Strength | 36.66% | 34.41% | 46.11% | ||
| Weighted Alpha | -44.82 | -1.32 | +61.15 | ||
| Today's Opinion | 100% Sell | 8% Sell | 64% Buy | ||
| Previous Opinion | 100% Sell | 8% Sell | 88% Buy | ||
| Last Month's Opinion | 100% Sell | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.65% since 04/22/24 | -1.71% since 04/22/24 | -3.34% since 04/22/24 | ||
| Low | 16.16 on 04/25/24 | 49.66 on 04/25/24 | 17.04 on 04/29/24 | ||
| High | 17.57 on 04/29/24 | 55.94 on 04/23/24 | 18.15 on 04/25/24 | ||
| 1-Month | |||||
| %Chg | -7.52% since 03/28/24 | -26.51% since 03/28/24 | -4.30% since 03/28/24 | ||
| Low | 16.16 on 04/25/24 | 49.66 on 04/25/24 | 17.04 on 04/29/24 | ||
| High | 18.63 on 04/04/24 | 69.19 on 04/01/24 | 18.20 on 04/09/24 | ||
| 3-Month | |||||
| %Chg | -37.91% since 01/29/24 | -20.62% since 01/29/24 | +58.97% since 01/29/24 | ||
| Low | 16.16 on 04/25/24 | 49.66 on 04/25/24 | 10.39 on 01/31/24 | ||
| High | 27.94 on 01/30/24 | 75.10 on 03/07/24 | 18.31 on 03/12/24 | ||
| 6-Month | |||||
| %Chg | -21.42% since 10/27/23 | +60.98% since 10/27/23 | +127.82% since 10/27/23 | ||
| Low | 16.16 on 04/25/24 | 32.42 on 10/30/23 | 4.18 on 11/22/23 | ||
| High | 32.59 on 12/22/23 | 75.10 on 03/07/24 | 18.31 on 03/12/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,753,340 | 2,766,817 | 2,717,203 | ||
| Shares Outstanding, K | 164,772 | 53,290 | 150,621 | ||
| Annual Sales | 726,440,000 | 110,320,000 | 257,890,000 | ||
| Annual Net Income | -61,290,000 | -70,690,000 | -205,350,000 | ||
| Last Quarter Sales | 231,040,000 | 63,150,000 | 63,610,000 | ||
| Last Quarter Net Income | 45,800,000 | 19,840,000 | 53,170,000 | ||
| 60-Month Beta | 0.37 | 0.02 | 1.17 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.28 on 02/27/24 | 0.42 on 02/28/24 | 0.33 on 03/13/24 | ||
| Latest Earnings Date | 05/08/24 | 05/13/24 | 05/01/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||